The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Confluent Inc shares valued at $306,697 were sold by Mac Ban Ryan Norris on May 22 ’25. At $21.21 per share, Mac Ban Ryan Norris sold 14,460 shares. The insider’s holdings dropped to 413,055 shares worth approximately $9.04 million following the completion of this transaction.
Also, Mac Ban Ryan Norris sold 9,476 shares, netting a total of over 206,861 in proceeds. Following the sale of shares at $21.83 each, the insider now holds 427,515 shares.
Before that, Sivaram Rohan had sold 27,710 shares from its account. In a trade valued at $604,909, the CHIEF FINANCIAL OFFICER traded Confluent Inc shares for $21.83 each. Upon closing the transaction, the insider’s holdings decreased to 27,710 shares, worth approximately $14.75 million.
As published in their initiating research note from Raymond James on April 11, 2025, Confluent Inc [CFLT] has been an Outperform and the price target has been revised to $30. Analysts at UBS upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late February. As of January 16, 2025, Morgan Stanley has decreased its “an Overweight” rating to a “an Equal-weight” for CFLT. Earlier on September 04, 2024, Robert W. Baird initiated its rating. Their recommendation was “a Neutral” for CFLT stock.
Analyzing CFLT Stock Performance
During the last five days, there has been a drop of approximately -3.65%. Over the course of the year, Confluent Inc shares have dropped approximately -21.71%. Shares of the company reached a 52-week high of $37.90 on 02/12/25 and a 52-week low of $18.26 on 04/07/25.
Support And Resistance Levels for Confluent Inc (CFLT)
According to the 24-hour chart, there is a support level at 21.33, which, if violated, would cause prices to drop to 20.78. In the upper region, resistance lies at 22.24. The next price resistance is at 22.60. RSI (Relative Strength Index) is 48.56 on the 14-day chart, showing neutral technical sentiment.
